References

  1. F. Gary Cunningham, et al., Williams Obstetrics, McGraw ­Hill: 2001.
  2. Michigan Department of Community Health, Informed Consent for Abortion, 2001.
  3. Andrzej Zachwieja, The Development of the Preborn Child, (photos)
  4. American College of Obstetricians & Gynecologists Practice Bulletin, number 67, October 2005.
  5. Warren Hern, Abortion Practice, Philadelphia: J.B. Lippincott Company, 1990.
  6. J. Brind, “Induced Abortion as an Independent Risk Factor for Breast Cancer: A Comprehensive Review and Meta-Analysis,” Journal of Epidemiology and Community Health, 50:481­496, 1996.
  7. Daling, J. et al, “Risk of Breast Cancer Among Young Women: Relationship to Induced Abortion,” Journal of the National Cancer Institute, Volume 86, #21, 1994.
  8. Garfinkle, B., et al, “Stress, Depression, and Suicide: A study of Adolescents in Minnesota,” Minneapolis: Univ. Minnesota Extension Service, 1986.
  9. http://www.guttmacher.org/sections/abortion.php
  10. Gissler, M., et al, Pregnancy associated deaths in Finland 1987­1994, Acta Obstetricia et Gynecologica Scandinavica 76:651­657 (1997).
  11. Gissler, M., et al, Pregnancy associated mortality after birth, spontaneous abortion, or induced abortion in Finland, 1987­2000., American Journal of OB/GYN 190: 422­427, 2004.
  12. Reardon, et al., Deaths associated with pregnancy outcome, Southern Med Journal, vol 95(8), Aug 2002.
  13. Speckard, A. & Rue, V. "Post Abortion Syndrome: An Emerging Public Health Concern" Journal of Social Issues 48:3, 95 ­120, 1992.
  14. Thorp, J.M., et al, Long­term physical and psychological health consequences of induced abortion: review of the evidence, OB GYN Survey, vol 58(1):67 ­79 ; 2002.
  15. Induced Abortion; ACOG patient education pamphlet; June 2001.
  16. Howe, et al, Induced abortion and breast cancer Int J Epidemiol 18:300­4; 1989.
  17. Calhoun, B., Induced abortion and risk of later premature births; Journal of American Physicians and Surgeons; 8(2): 46­49; 2003.
  18. Stenchever, et al, Comprehensive Gynecology, 4th Edition, Mosby, Inc. 2001.
  19. Medscape Medical News; FDA Safety Labeling Change: Mifeprex; October 26, 2005. http://www.medscape.com/medscapetoday
  20. Induction of Labor; ACOG Practice Bulletin 10; Clinical management guidelines for OB/GYNs. Nov. 99.
  21. Gary, M. and Harrison, D., “Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient,” The Annals of Pharmacology, vol. 40, February 2006.
  22. Rue, V.M., Coleman, P.K., et al ; “Induced Abortion and Traumatic Stress: A Preliminary Comparison of American and Russian Women.” www.medscimonit.com 2004; 10(10): SR5-16.
  23. Mifeprex package insert; 2000.
  24. FDA Drug Updates: http://www.fda.gov/cder/drug/infopage/mifepristone/mifepristone_historical.htm
  25. Centers for Disease Control, “Abortion Surveillance U.S., 2003,” Morbidity & Mortality Weekly Report, Nov. 24, 2006/55/SS­11.
  26. TeLinde’s Operative Gynecology 8th Edition; Editors J.A. Rock J.D. Thompson; 1997 Lippincott­Raven, pp 485­497.